Speakers

Explore the MSS2026 speaker lineup across our four thematic streams. Click any speaker to read their talk and abstract. This list continues to grow as additional speakers are confirmed.

High Impact Sessions & Technology Insights

Thomas J. Cradick

Gene Editing Frontiers LLC

Gene Editing and Delivery Breakthroughs: Overcoming therapeutic barriers for unmet needs

Gary Gilleskie

BTEC

Advancing biomanufacturing education: adapting workforce development for the next generation of biologics

Anže Videnič

BioSistemika

Don't trust the AI - audit it: Why regulated science is uniquely ready for AI

Oskar Smrzka

Ablevia

ADAscape™: High-Resolution Epitope Profiling for Anti-Drug and Anti-Vector Antibodies

Matej Stupar

Katezai

Scaling the future: the evolution of ATMP facility design from Boutique labs to Flexible Manufacturing Platforms

Janez Štrancar

Infinite d.o.o.

Digital twins of disease evolution to understand disease and its treatment ahead of time

HM

Hans Willhelm Meyers

Dompatent

How can commercially promising scientific results be safeguarded?

Florence Salmon

Roche

Beyond the sequence: how intended use shapes the regulatory pathway

Evan Yellin

EC M&A

Fundamental growth milestones and positioning for a high value strategic exit

Špela Miroševič

CTNNB1 Foundation

Developing gene therapy with no plan B: A mother's journey from diagnosis to first-in-human

Christina Klasen

Particle Metrix

Advancing Formulation Development with ZetaView® Evolution NTA: High-Resolution Analysis of Lipid Nanoparticles and Viral Vectors

UA

Uroš Andjelković

SavantiVir

Early stage preclinical development of new biological pan-antiviral

Denis Bešić

NeoVac

NeoVac: Building the Next Generation of RNA Delivery

Dora Lalić

GlycanAge

GlycanAge - a tool for personalized health tracking

Show more

Nucleic Acids and LNPs

Dan Peer

Laboratory of Precision Nanomedicine, Tel Aviv University

The RNA revolution: from novel vaccines to therapeutic genome editing

Jacek Lubelski

NanoCell

tLNP as a Novel Gene Therapy Vector to Deliver DNA

Linpeng Wu

RiboX

Purification Strategies of Circular RNA

Mukesh Chauhan

BioNet Asia

Evolution of Vaccine Technologies: From Recombinant Vaccines to pDNA and mRNA Platforms

Juergen Mairhofer

enGenes Biotech

iCAP: Integrated Continuous and Automated Platform for Plasmid Production

Mojca Tajnik Sbaizero

Sartorius BIA Separations

Chromatographic LNP Purification for Enhanced Purity and Activity in CRISPR, CAR-T, and Vaccine Manufacturing

Miyuki Hori

TAGCyx Biotechnologies

Applications of highly functional Xenoligo ssDNA aptamer technology for medical and bioprocessing

John McHale

Arcturus

Enabling Scalable Chromatography from Analytical to Preparative Purification for LNPs

Stella Kounadi

4basebio

Enzymatically Synthesized DNA Templates Enable Scalable mRNA manufacture and Robust PolyA Tail Integrity

Tristan Kovačič

Sartorius BIA Separations

A Comprehensive Manufacturing and Characterization Approach to Passive or Active Targeted LNP-Based Biopharmaceuticals

Kevin Ainger

GaletaBio

Applied chromatography technologies and analytical applications for preparations of ultra-pure minicircle plasmid DNAs

Urh Černigoj

Sartorius BIA Separations

Simultaneous development of chromatographic monoliths and purification methods to overcome bottlenecks in downstream processing of large nucleic acids

Sven Even Borgos

Sintef Industry

Monolith liquid chromatography for recovery and purification of intact lipid nanoparticles shows full in vivo compatibility

Urban Bezeljak

COBIK

mRNA gene electrotransfer of IL-12 in melanoma and colorectal carcinoma: From in vitro characterization to in vivo antitumor efficacy

Mark Stoops

NCSU

Continuous in-situ Bioprocessing for Scalable mRNA Production: Advancing Manufacturing for Vaccines and Genetic Medicines

Aydin Kavara

Cytiva

The use of Mustang Q membrane chromatography as the capture step in a 2-step plasmid DNA purification strategy

Heinrich Haas

NeoVac

Advanced quality control strategies for mRNA nanoparticles

Jasmina Puc

GaletaBio

Purity and Impurity Control in IVT-Derived mRNA Therapeutics

María Alicia Delfino

LITAN, CONICET - UBA

Scalable purification of a DNA-launched RNA replicon-based vaccine candidate against Trypanosoma cruzi infection using monolithic chromatography technology

Aslan Dehghani

Sartorius

End to End Lipid Nanoparticle Workflow; From Formulation to Large Scale Manufacturing

Rafaela Gaspar

Universidade da Beira Interior

Development of scalable purification strategy for minicircle DNA vaccines in different monoliths

Show more

Proteins

Michael Lukesch

VALANX Biotech

Finding the Golden Site: How synthetic amino acids and third-generation click chemistry enable the next generation of protein conjugates

Andre Germishuizen

National Bioproducts Institute (NBI)

Commercial-Scale Evaluation of a CIMmultus® Mixed-Mode Monolith for IgG Production

Aleš Štrancar

BIA Separations Inc

Away from Cohn, away from EtOH, the next generation plasma fractionation process

Boštjan Kokot

IJS

Advanced fluorescence microscopy platforms for imaging of (biological) samples at various spatial and time scales

GM

Gabriele Malagoli

Università di Bologna

A combined 3D printing–phase inversion process as a new platform for monolith production

Oskar Smrzka

Ablevia

Precision Management of Anti-Drug and Anti-Vector Antibodies: Deep Epitope Profiling and Adaptable Molecular Decoys for Selective ADA Removal

Konstantin Glebov

University of Plymouth, Exosome Consulting

Closing the Target-Validation Gap for Complex Biologics with an Integrated AI Knowledge Platform

Djuro Josić

Faculty of Medicine, Juraj Dobrila University

Chromatography on newly developed monolithic supports for biological nanoparticles and large biomolecules

Manuela Bartolini

Alma Mater Studiorum University of Bologna

Monolith-based Immobilized Enzyme Reactors: Enabling Technologies for Diverse and Evolving Landscapes

Albert Farrugia

The University of Western Australia

Plasma fractionation - Past, present and future

Yow-Pin Lim

ProThera Biologics, Inc

Efficient and Scalable Purification of Plasma derived Therapeutic Proteins

Lucija Dončević

Genos

Purification of FIX from Cryopoor Plasma using DEAE and SO₄ Monolithic Supports

Hana Kokot

Jožef Stefan Institute

A general, biologically-interpretable image analysis pipeline for microscopy of pharmaceutical agents in biological systems

Simone Dimartino

University of Edinburgh

Technoeconomic and sustainability evaluation of 3D printed monolithic adsorbers for integrated clarification and capture of therapeutic antibodies

Tomislav Friganović

Genos

Direct chromatographic capture of therapeutic proteins from undiluted human plasma on large channel monoliths

UA

Uros Andjelkovic

SavAntiVir

Proteinaceous pan-antiviral entry inhibitor for crossing the gap in pandemic preparedness

Irena Trbojević Akmačić

Genos

High-Throughput IgG Glycosylation Analysis Using Protein G Monoliths

Wendy A. Mensah

University of Bologna

From Hours to Minutes: Development of an Oriented PNGase F IMER for Automated Glycoprofiling

Matjaž Peterka

Sferogen

nanoSFERIC™: A Novel Flexible Nanoparticle Vaccine Platform for Infectious Disease and Cancer

Show more

Viruses and Viral Vectors

Klaus Graumann

Phoenestra GmbH

From consistent manufacturing to understanding mechanisms of action (MoAs) for extracellular vesicles from MSC

Binod Prasad

Abalos Therapeutics

From viral complexity to clinical manufacturing: a platform approach for cancer immunotherapies

Andrzej Noyszewski

VerumGen Labs

Universal AAV Standard: Advancing Standardization in AAV Genome Quantification and Quality Assessment

Robert Kotin

Massachusetts Institute of Technology

A Long-Term Perspective on AAV Gene Therapy

Vera Schoft

A-SpecTar

Programmable Virus-Like Particles for Targeted Drug Delivery

Niren Shah

Cove Therapeutics

Non-viral, polymeric nanoparticle gene therapy for ocular disorders

Wolfgang Schönfeld

A-SpecTar

Curative Gene Therapy for Hypophosphatasia and Thrombotic Thrombocytopenic Purpura

Beata Halassy

University of Zagreb

Ex tempore Oncolytic Virus Manufacturing: A Feasibility Assessment

Jaap Twisk

Uniqure

Characterization and release testing of AAV-based products for clinical use – where are we?

Nataša Zarovni

RoseBio

Long and winding road to scalability and clinical viability of Extracellular Vesicle–based therapies

David Dobnik

National Institute of Biology

Impact of Genome Fragmentation and Empty Capsids on rAAV Functional Potency in Liver Cells

Adela Štimac

University of Zagreb

Native Elution Immunoaffinity Chromatography for Efficient Purification of Vesicular Stomatitis Virus

Danish J. Malik

Loughborough University

Evaluation of PrimaS and PrimaT Monolithic Chromatography Columns for Purification of Therapeutic Bacteriophages Targeting ESKAPE Pathogens

Stefano Menegatti

North Carolina State University

Affinity and mixed-mode convective adsorbents for the purification and enrichment of vectors for cell and gene therapies

Martina Lokar Kosmač

COBIK

Engineered recombinant baculoviruses for efficient production of enveloped virus-like particles

Lior Shaltiel

NurExone Biologic

Harnessing Nature's Nanoparticle: Process Development of Exosomes for Drug Delivery

Thomas Muster

BlueSky Immunotherapies

Interferon-inducing viral vector immunotherapy reprograms tumor immunity and eliminates persistent HPV infection

Show more